We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-8.3%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$141B
AUM Growth
-$9.21B
Cap. Flow
+$6.71B
Cap. Flow %
4.75%
Top 10 Hldgs %
17.26%
Holding
9,177
New
664
Increased
3,305
Reduced
3,724
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 8.11%
2 Healthcare 6.31%
3 Energy 6.06%
4 Technology 5.81%
5 Industrials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCTY
7551
The9 Ltd
NCTY
$68.1M
$6K ﹤0.01%
+16
New +$6.06K
NL icon
7552
NLI Holdings
NL
$281M
$6K ﹤0.01%
2,147
+5
+0.2% +$25
NRC icon
7553
NRC Health Common Stock
NRC
$432M
$6K ﹤0.01%
541
-474
-47% -$6.3K
NSPR icon
7554
InspireMD
NSPR
$30.4M
0
NTIP icon
7555
Network-1 Technologies
NTIP
$37M
$6K ﹤0.01%
3,086
+2,555
+481% +$5.6K
OGEN icon
7556
Oragenics
OGEN
$2.26M
0
ONTO icon
7557
Onto Innovation
ONTO
$12.9B
$6K ﹤0.01%
459
+290
+172% +$4.11K
OPK icon
7558
PUT
Opko Health
OPK
$985M
$6K ﹤0.01%
700
-5,000
-88% -$66.2K
RVP icon
7559
Retractable Technologies
RVP
$19.8M
$6K ﹤0.01%
1,788
-2,294
-56% -$8.77K
RXD icon
7560
ProShares UltraShort Health Care
RXD
$3.23M
$6K ﹤0.01%
25
-141
-85% -$28.4K
SFST icon
7561
Southern First Bancshares
SFST
$591M
$6K ﹤0.01%
271
SGMO
7562
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$6K ﹤0.01%
1,000
SIRI icon
7563
PUT
SiriusXM
SIRI
$9.98B
$6K ﹤0.01%
150
SPGM icon
7564
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.72B
$6K ﹤0.01%
+202
New +$6.41K
SPXS icon
7565
CALL
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$339M
$6K ﹤0.01%
1
SQNS
7566
Sequans Communications SA
SQNS
$36.4M
$6K ﹤0.01%
56
+47
+522% +$6.08K
TBPH icon
7567
Theravance Biopharma
TBPH
$874M
$6K ﹤0.01%
500
-374
-43% -$4.76K
TRIP icon
7568
CALL
TripAdvisor
TRIP
$1.65B
$6K ﹤0.01%
100
TRX icon
7569
TRX Gold Corp
TRX
$254M
$6K ﹤0.01%
19,599
+14,599
+292% +$5.05K
VGZ icon
7570
Vista Gold
VGZ
$251M
$6K ﹤0.01%
20,943
+16,798
+405% +$4.71K
VRDN icon
7571
Viridian Therapeutics
VRDN
$2.09B
$6K ﹤0.01%
+28
New +$9.83K
IRD
7572
Opus Genetics
IRD
$306M
$6K ﹤0.01%
23
-35
-60% -$9.51K
ACER
7573
DELISTED
Acer Therapeutics Inc
ACER
$6K ﹤0.01%
198
EMAN
7574
DELISTED
eMagin Corporation
EMAN
$6K ﹤0.01%
2,700
-7,674
-74% -$20K
BICK
7575
DELISTED
First Trust BICK Index Fund
BICK
$6K ﹤0.01%
300
-464
-61% -$9.56K

Similar funds

UBS Group's Q3 2015 Portfolio in Review

As of Q3 2015, UBS Group held 9,177 positions worth $141B, down 6.1% from $150B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $6.71B of net new capital in Q3 2015, opening 664 new positions and adding to 3,305 existing holdings. Its largest new stake was Kraft Heinz: 1,448,913 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Apple, an estimated $399M trimmed.

  • UBS Group's largest Q3 2015 buy was Kraft Heinz: 1,448,913 shares worth $102M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.97B increase.
  • UBS Group's biggest Q3 2015 reduction was Apple, cutting an estimated $399M.
  • UBS Group fully exited OMNICARE INC in Q3 2015, selling an estimated $227M.
  • UBS Group's ten largest holdings make up 17% of its $141B portfolio in Q3 2015.
  • UBS Group opened 664 new positions and closed 707 in Q3 2015.
  • UBS Group's portfolio value fell 6.1% quarter-over-quarter to $141B.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.